Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Jackson

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Heart (British Cardiac Society)|April 30, 1999
Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk menI U Haq, L E Ramsay, W W Yeo, et al.
Biochemical Pharmacology|October 1, 1990
Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprololS S Murthy, H U Shetty, W L Nelson, et al.
JAMA|February 10, 1999
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention StudyI U Haq, E J Wallis, W W Yeo, et al.
Pharmacogenetics|April 1, 1992
Evidence for a dissociation in the control of sparteine, debrisoquine and metoprolol metabolism in NigeriansM S Lennard, A O Iyun, P R Jackson, et al.
Lancet (London, England)|March 14, 1992
Investigation of selected patients with hypertension by the rapid-sequence intravenous urogramH A Cameron, C F Close, W W Yeo, et al.
Journal of Hypertension|December 23, 1999
Implication of recent trials with b-hydroxy-b-methylglutaryl coenzyme A reductase inhibitors for hypertension managementI U Haq, E J Wallis, P R Jackson, et al.
BMJ (Clinical Research Ed.)|April 24, 1999
Cholesterol screening and management guidelines. Policy based on Sheffield table fully satisfies authors' criteriaL E Ramsay, E J Wallis, I U Haq, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Variability of plasma drug concentrations--a replyM S Lennard, P R Jackson, L E Ramsay, et al.
Lancet (London, England)|March 3, 1998
Drug therapy for coronary heart disease: the Sheffield tableL E Ramsay, E J Wallis, I U Haq, et al.
Journal of Hypertension|November 14, 1997
Panic disorder, anxiety and depression in resistant hypertension--a case-control studyS J Davies, P Ghahramani, P R Jackson, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Heart (British Cardiac Society)|April 30, 1999
Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk menI U Haq, L E Ramsay, W W Yeo, et al.
Biochemical Pharmacology|October 1, 1990
Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprololS S Murthy, H U Shetty, W L Nelson, et al.
JAMA|February 10, 1999
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention StudyI U Haq, E J Wallis, W W Yeo, et al.
Pharmacogenetics|April 1, 1992
Evidence for a dissociation in the control of sparteine, debrisoquine and metoprolol metabolism in NigeriansM S Lennard, A O Iyun, P R Jackson, et al.
Lancet (London, England)|March 14, 1992
Investigation of selected patients with hypertension by the rapid-sequence intravenous urogramH A Cameron, C F Close, W W Yeo, et al.
Journal of Hypertension|December 23, 1999
Implication of recent trials with b-hydroxy-b-methylglutaryl coenzyme A reductase inhibitors for hypertension managementI U Haq, E J Wallis, P R Jackson, et al.
BMJ (Clinical Research Ed.)|April 24, 1999
Cholesterol screening and management guidelines. Policy based on Sheffield table fully satisfies authors' criteriaL E Ramsay, E J Wallis, I U Haq, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Variability of plasma drug concentrations--a replyM S Lennard, P R Jackson, L E Ramsay, et al.
Lancet (London, England)|March 3, 1998
Drug therapy for coronary heart disease: the Sheffield tableL E Ramsay, E J Wallis, I U Haq, et al.
Journal of Hypertension|November 14, 1997
Panic disorder, anxiety and depression in resistant hypertension--a case-control studyS J Davies, P Ghahramani, P R Jackson, et al.
Pageof 14